| Financial Year |
March 31 2023 |
| Monetary Funds |
384,614,762.42 |
| Held-for-trading Financial Assets |
134,814,000.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
853,874,450.62 |
| Advances to Suppliers |
249,938,196.67 |
| Other Receivables |
1,810,092,367.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,443,333.26 |
| Inventories |
1,160,091,902.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
160,542,215.21 |
| Total Current Assets |
4,986,155,727.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,000,000.00 |
| Long-term Equity Investment |
205,461,237.35 |
| Investment Properties |
-- |
| Fixed Assetes |
2,721,995,431.41 |
| Under-construction Projects |
385,763,485.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
399,213,379.71 |
| R&D expenses |
-- |
| Goodwill |
612,518,931.74 |
| Long-Term Deferred and Prepaid Expenses |
57,166,534.85 |
| Deferred Income Tax Assets |
396,971,130.08 |
| Other Non-Current Assets |
233,076,007.00 |
| Sub-Total of Non-Current Assets |
5,068,564,137.81 |
| Total Assets |
10,054,719,865.46 |
| Short-Term Loans |
3,216,382,427.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
968,456,699.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,194,082.57 |
| Taxes Payable |
68,625,960.43 |
| Interest Payable |
590,242,431.29 |
| Dividend Payable |
1,770,211.71 |
| Other payables |
972,883,172.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
940,423,445.34 |
| Other Current Liabilities |
246,629,856.26 |
| Sub-Total of Current Liabilities |
6,652,080,321.10 |
| Long-term Loans |
279,259,553.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
155,965,545.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,427,224,318.91 |
| Deferred Income Tax Liabilities |
43,946,271.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,981,280,898.61 |
| Total Liabilities |
8,633,361,219.71 |
| Paid-In Capital(Or Share Stock) |
580,772,873.00 |
| Capital Surplus |
2,154,760,082.21 |
| Surplus Reserve |
240,601,760.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,765,086,451.15 |
| Minority Stockholder's Interest |
133,778,257.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,287,580,388.51 |
| Owner's Equity（Stockholder's Equity） |
1,421,358,645.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,054,719,865.46 |
